Implications of detection and characteristics of primary circulating prostate cells for surgical treatment of prostate cancer
July 22nd, 2010 Posted in prostatectomyA recent study at Hospital de Carabineros de Chile, Chile, had two objectives:
1. To determine the frequency of primary circulating prostate cells (CPCs) in men with prostate cancer at the time of diagnosis, the association with micrometastasis, sub-classification for CD82 and the relation with pathological stage.
2. To determine their clinical usefulness to identify patients in whom radical prostatectomy would be first choice therapy.
The study finds that the detection of CPCs and sub-classification with CD82 could be clinically useful to identify men with a significantly lower risk of micrometastais and as a consequence to identify men in whom radical prostatectomy could be the best initial treatment.